Mechanism(s) Of Leukemogenesis In Disease Models

疾病模型中白血病发生的机制

基本信息

项目摘要

Public health concern over ionizing radiation and benzene, a radiomimetic, because of their potential to induce cancer. Exposure to radiation and benzene is associated with depression of blood forming elements leading to anaplastic anemia, followed by myelodysplastic syndrome (MDS) and, ultimately, to leukemia or lymphoma. Inhalation or dermal exposure to benzene results in a slower rate of delivery and a greater internal dose than other routes of exposure. At equivalent oral dose (mg/kg), more benzene is expired unmetabolized after administration by the oral route (60%) than by inhalation (14%). Mice may also produce a greater variety of benzene metabolites by inhalation. Most critical to selection of dose for experimental studies is to know the exposure level that becomes saturating to pathways of detoxification. For inhalation exposure this is 200 ppm (6 h TWA. Between 5 and 50 ppm benzene (6 h TWA, there is no significant difference between urinary metabolites. Available data also suggests that the ratio of hydroquinone or muconic acid to phenol ratio after inhalation exposure to 50 ppm (6 h TWA) is closer between mice and humans than either rats or Cynomolgus monkeys. This is critical because these may be the most toxic benzene intermediates. Thus, an exposure model must take into account saturation of benzene metabolism pathways, available data on exposures and high-affinity, low capacity pathways of metabolism that result in the most hematotoxic intermediates. We have been able to show that p53 deficient mice exposed to low levels (100 ppm, 6 h TWA) develop thymic lymphomas rapidly whereas mice exposed to higher levels (200 ppm, 6 h TWA) less rapidly and a significantly decreased incidence. In these studies, benzene induced lymphomas in the p53 deficient mice were: 1) clonal (T-cell receptor rearrangements were common), 2) showed a pattern of loss or deletions in chromosome 11 carrying the p53 wildtype allele different from sporadic lymphomas, and 3) showed a pattern of dysregulation of critical genes in both the p53 and Rb pathways that affected cell cycle control and population growth and apoptosis. We are continuing to investigate the effect of benzene dose and dose rate exposure by inhalation or drinking water. Using low doses and reduced frequency of exposure, metabolic pathways in the hematopoietic stem cell compartment that show high affinity for oxidation of benzene to mutagenic metabolites are targeted. At high doses and rates, these data suggest that conjugated metabolites are efficiently excreted. More research is required to investigate these phenomena.
公众健康对电离辐射和苯(一种拟辐射物质)的担忧,因为它们有可能诱发癌症。接触辐射和苯与造血元素抑制有关,导致再生障碍性贫血,随后出现骨髓增生异常综合征 (MDS),最终导致白血病或淋巴瘤。与其他接触途径相比,吸入或皮肤接触苯会导致输送速度较慢和内部剂量更大。在同等口服剂量(mg/kg)下,口服给药后未代谢的苯(60%)比吸入给药(14%)多。小鼠也可能通过吸入产生更多种类的苯代谢物。选择实验研究剂量最关键的是了解解毒途径饱和的暴露水平。对于吸入暴露,该浓度为 200 ppm(6 小时 TWA)。在 5 和 50 ppm 苯(6 小时 TWA)之间,尿液代谢物之间没有显着差异。现有数据还表明,吸入暴露于 50 ppm(6 小时 TWA)后,小鼠和人类之间的对苯二酚或粘康酸与苯酚的比率比大鼠或食蟹猴更接近。这是 至关重要,因为这些可能是毒性最强的苯中间体。因此,暴露模型必须考虑苯代谢途径的饱和度、暴露的可用数据以及产生最具血液毒性中间体的高亲和力、低容量的代谢途径。我们已经能够证明,暴露于低水平(100 ppm,6 小时 TWA)的 p53 缺陷小鼠会迅速发展为胸腺淋巴瘤 而暴露于较高浓度(200 ppm,6 小时 TWA)的小鼠则速度较慢且发病率显着降低。在这些研究中,p53 缺陷小鼠中苯诱导的淋巴瘤为:1) 克隆性(T 细胞受体重排很常见),2) 携带 p53 野生型等位基因的 11 号染色体显示出与散发性淋巴瘤不同的丢失或缺失模式, 3) 显示 p53 和 Rb 通路中关键基因的失调模式,影响细胞周期控制以及群体生长和凋亡。我们正在继续研究吸入或饮用水苯剂量和剂量率暴露的影响。使用低剂量和减少暴露频率,针对造血干细胞区室中对苯氧化成诱变代谢物表现出高亲和力的代谢途径。在高剂量和高速率下,这些数据表明缀合代谢物可以有效地排出体外。需要更多的研究来调查这些现象。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN EDGAR FRENCH其他文献

JOHN EDGAR FRENCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN EDGAR FRENCH', 18)}}的其他基金

Mechanism(s) of Leukemogenesis in Genetically-Altered Mouse Models
基因改造小鼠模型中白血病发生的机制
  • 批准号:
    6432229
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Carcinogen inactivation of tumor suppressor genes in p53 haploinsufficient mice.
p53 单倍体不足小鼠中肿瘤抑制基因的致癌灭活。
  • 批准号:
    6432252
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CARCINOGEN INACTIVATION OF TUMOR SUPPRESSOR GENES IN P53 HAPLOINSUFFICIENT MICE.
P53 单倍体不足小鼠中肿瘤抑制基因的致癌灭活。
  • 批准号:
    6289910
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Mechanism(s) Of Leukemogenesis In Genetically-altered Mo
基因改变的 Mo 中白血病发生的机制
  • 批准号:
    6837354
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Carotenoid/Retinoid Modulation of Cellular Redox/Cancer
类胡萝卜素/类视黄醇对细胞氧化还原/癌症的调节
  • 批准号:
    6432261
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Genetic Susceptibility to Loss of Tumor Suppressor Gene Function
肿瘤抑制基因功能丧失的遗传易感性
  • 批准号:
    7967960
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Genetic Susceptibility to Loss of Tumor Suppressor Gene
肿瘤抑制基因丢失的遗传易感性
  • 批准号:
    7327256
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CAROTENOID/RETINOID MODULATION OF CELLULAR REDOX STATUS AND CANCER
类胡萝卜素/类维生素A调节细胞氧化还原状态和癌症
  • 批准号:
    6293840
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Carcinogen Inactivation Of Tumor Suppressor Genes In P53
P53 中肿瘤抑制基因的致癌物质失活
  • 批准号:
    6542232
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Carcinogen Inactivation Of Tumor Suppressor Genes In P53
P53 中肿瘤抑制基因的致癌物质失活
  • 批准号:
    6681846
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Core 3 - Biomarkers and Product Evaluation
核心 3 - 生物标志物和产品评估
  • 批准号:
    10628258
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Impact of benzene-induced MIA on fetal T cell development
苯诱导的 MIA 对胎儿 T 细胞发育的影响
  • 批准号:
    10605881
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development of Catalytic Glycosylations and Biologically Important Glycosaminoglycans
催化糖基化和具有生物学重要性的糖胺聚糖的发展
  • 批准号:
    10622180
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
GCS-CEAS: a novel tool for exposure assessment during disaster response
GCS-CEAS:灾难响应期间暴露评估的新工具
  • 批准号:
    10699942
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Physics-informed Machine Learning approach for a selective, sensitive, and rapid sensor for detecting unsafe levels of carcinogenic/toxic VOCs
基于物理的机器学习方法,用于选择性、灵敏且快速的传感器,用于检测致癌/有毒 VOC 的不安全水平
  • 批准号:
    10600819
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Impact of Landfill Mitigation Efforts to Reduce Air Toxics in Bristol, Tennessee and Virginia
布里斯托尔、田纳西州和弗吉尼亚州垃圾填埋场缓解措施对减少空气有毒物质的影响
  • 批准号:
    10693558
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Drinking water contaminants and fetal loss in Northern California
北加州的饮用水污染物和胎儿丢失
  • 批准号:
    10727706
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A Preconception Cohort Study on Oil and Gas Development, Fertility, and Pregnancy
关于石油和天然气开发、生育力和怀孕的孕前队列研究
  • 批准号:
    10480218
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
ELIMINATION OF AIRBORNE VOLATILE COMPOUNDS THROUGH INCORPORATION OF ADVANCED 3D NANOSTRUCTURED CATALYTIC COATINGS IN ADSORPTION/DECOMPOSITION AIR PURIFICATION SYSTEMS
通过在吸附/分解空气净化系统中采用先进的 3D 纳米结构催化涂层消除空气中的挥发性化合物
  • 批准号:
    10556402
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Impact of BTEX Chemical Exposure During Pregnancy to Maternal and Fetal Well-Being
怀孕期间接触 BTEX 化学品对母亲和胎儿健康的影响
  • 批准号:
    10352965
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了